SCHEMBL13005652

SCHEMBL13005652

COc1c(CC(C)C)cccc1-c1cccc(C(=O)N[C@H](CCc2ccccc2)CN(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
CTSG P08311 1/20 0.41
CTRB1 P17538 1/20 0.41
F10 P00742 2/20 0.41
F2 P00734 1/20 0.41
PRSS1 P07477 1/20 0.41
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
HPGD P15428 1/20 0.40
ALDH1A1 P00352 1/20 0.39
GPR139 Q6DWJ6 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
UTS2R Q9UKP6 1/20 0.38
MME P08473 1/20 0.38
MMEL1 Q495T6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005647 1.00 TAS1R3 (0.43) TAS1R3TAS1R1CTSGCTRB1F10
SCHEMBL13005524 0.93 MME (0.43) CTRB1ALDH1A1GPR139MMEMMEL1
SCHEMBL13005496 0.93 MME (0.43) CTRB1ALDH1A1GPR139MMEMMEL1
SCHEMBL13005481 0.88 CTSL (0.41) TAS1R3TAS1R1UTS2R
SCHEMBL13005472 0.88 CTSL (0.41) TAS1R3TAS1R1UTS2R
SCHEMBL13061226 0.87 ROCK2 (0.44) CTRB1ALDH1A1GPR139MMEMMEL1
SCHEMBL13060643 0.87 ROCK2 (0.44) CTRB1ALDH1A1GPR139MMEMMEL1
SCHEMBL13005639 0.86 ROCK2 (0.38) TAS1R3TAS1R1UTS2R
SCHEMBL13005620 0.86 ROCK2 (0.38) TAS1R3TAS1R1UTS2R
SCHEMBL13005693 0.85 ROCK2 (0.50) UTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed